CU Anschutz Wins FDA Clearance for CAR T Cancer Trial
Aurora, Colorado, U.S., September 10, 2026 University of Colorado Anschutz Medical Campus (CU Anschutz) has received U.S. Food and...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Aurora, Colorado, U.S., September 10, 2026 University of Colorado Anschutz Medical Campus (CU Anschutz) has received U.S. Food and...
Limerick, Ireland, September 10, 2026 Johnson & Johnson has announced that it has received CE Marking for ACUVUE OASYS...
